News & Blog

Author Archives: Tom Halkin

A Step Toward Identifying Risk Factors for Glioma

In 2007, the National Brain Tumor Society provided funding for an international project to search for more clues to one of the biggest mysteries of brain tumors – what causes them to develop. This week, researchers from this project, dubbed the Gliogene Consortium, published preliminary results from their study, which suggest rare mutations in a […]

Five Key Updates from the 2014 Scientific Meeting of the Society for Neuro-Oncology

The Society for Neuro-Oncology (SNO) Annual Scientific Meeting is a multi-day conference that serves as one of the most important gatherings in the field of brain tumor research and drug development. Over three days, presentations are given on some of the most promising research efforts in the field, as well as critical updates on many […]

Encouraging Results from Novocure Clinical Trial

Novocure, a company that creates medical devices to treat cancer, announced this weekend that their Novo-TTF-100A system (now being called Optune), in combination with temozolomide (also know as Temodar or TMZ), demonstrated improved survival in newly diagnosed glioblastoma multiforme (GBM) patients in a clinical trial, compared with temozolomide alone. The announcement was made at the […]

Share